CELLFLOW S.L
Hoja B603047· NIF B56504095
- Registered address :
- Activity :
- Investigación y desarrollo experimental en biotecnología
- Legal form :
- Sociedades de responsabilidad limitada
- Share capital :
- 20 200,00 €
- Incorporation :
- 19/10/2023
- Directors :
- Bekir Belce, Yonca Belce
Legal information
Legal information for CELLFLOW S.L
Activity
CELLFLOW S.L is a Sociedades de responsabilidad limitada with its registered office in Barcelona, Cataluña. Its declared activity is “Investigación y desarrollo experimental en biotecnología” (CNAE 7211). It was incorporated on 19 October 2023. The Spanish commercial register has published 4 filings for this company, from 19 October 2023 to 8 May 2026, across 3 distinct types of filing. Its registered share capital is 20 200,00 €.
Economic activity (CNAE)
7211 · Investigación y desarrollo experimental en biotecnología
Corporate purpose
ACTIVIDAD PRINCIPAL: 7211 / INVESTIGACION Y DESARROLLO EXPERIMENTAL EN BIOTECNOLOGIA. OTRAS ACTIVIDADES: 7120 / ENSAYOS Y ANALISIS TECNICOS.
Directors and representatives
Directors
Current
- Bekir BelceSince 11/10/2023Administrador Solidario
- Yonca BelceSince 11/10/2023Administrador Solidario
Directors network map
Registered actos
- Ampliación de capitalPublished 08/05/2026· Registered 30/04/2026· I/A 3
- ConstituciónPublished 19/10/2023· Registered 11/10/2023· I/A 1
- NombramientosPublished 19/10/2023· Registered 11/10/2023· I/A 1
Capital · events
- 08/05/2026Ampliación de capitalResulting capital: 20 200,00 € (+20 000,00 €)
- 19/10/2023ConstituciónInitial capital: 200,00 €
Importes obtenidos del BORME cuando se publican (importe de la operación y capital resultante). Algunos anuncios no lo publican; en ese caso consulte el PDF original.
Timeline (BORME)
- 08/05/2026#9214737Ampliación de capital
CELLFLOW S.L. Ampliación de capital. Capital: 20.000,00 Euros. Resultante Suscrito: 20.200,00 Euros. Datos registrales. S 8 , H B 603047, I/A 3 (30.04.26).
- 14/04/2025#8590431
CELLFLOW S.L. Otros conceptos: ADQUISICION DEL CARACTER DE EMERGENTE (LEY 28/2022) CON FECHA 5 DE MARZO DE 2025. PERIODO DE DISFRUTE DE LOS BENEFICIOS: 7 AÑOS. Datos registrales. S 8 , H B 603047, I/A 2 ( 8.04.25).
- 19/10/2023#7753809ConstituciónNombramientos
CELLFLOW S.L. Constitución. Comienzo de operaciones: 5.12.23. Objeto social: ACTIVIDAD PRINCIPAL: 7211 / INVESTIGACION Y DESARROLLO EXPERIMENTAL EN BIOTECNOLOGIA. OTRAS ACTIVIDADES: 7120 / ENSAYOS Y ANALISIS TECNICOS. Domicilio: CL LLULL NUM.321 (BAR…
Official documents
Official Registro Mercantil documents that we obtain and deliver to you as PDFs.
Nota informativa mercantil (company extract)
Current registry status: administradores and apoderados with their DNI, objects, capital, registered address and latest accounts filing.
Public
Filed annual accounts
Actual image of the filing for each financial year: balance sheet, profit and loss account and shareholder structure.
Public
Certified articles of association
The company's articles of association in force, certified by the registrador.
Public· Incorporated 2023
Certificate of powers of attorney
Powers in force held by a given apoderado (state their NIF or name).
Public
Certificate of good standing and current officers
Conclusive certificate of existence, good standing and the cargos currently in office.
Public
Certificate of beneficial ownership
The company's official beneficial owners.
Requires a legitimate interest (shareholder, director or obliged entity)
Credit risk report
Commercial credit risk report on the company.
Public
Official documents from Spain's Registro Mercantil · delivered as PDFs. Price set by the official arancel, we send a quote once you request one.
Contact details
Prospect
Spanish companies in the same line of business — Investigación y desarrollo experimental en biotecnología — are listed together.